SuperworthCore Scientific EPS CORZ
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- −$4.23
- Latest quarter, Q2 FY26
- −$3.32
- Fiscal year 2025
- $1.35
Core Scientific's earnings per share was −$4.23 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$3.32.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $1.35 | n/a |
| FY2024 | −$6.24 | n/a |
| FY2023 | −$0.64 | n/a |
| FY2022 | −$6.31 | n/a |
| FY2021 | −$0.43 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$3.32 | n/a | −$4.23 | |
| Q1 FY26 | −$1.06 | −185% | −$0.95 | |
| Q4 FY25 | $0.60 | n/a | $1.35 | |
| Q3 FY25 | −$0.45 | n/a | −$0.05 | |
| Q2 FY25 | −$0.04 | n/a | −$0.77 | |
| Q1 FY25 | $1.24 | +59% | −$5.78 | |
| Q4 FY24 | −$0.80 | n/a | −$6.24 | |
| Q3 FY24 | −$1.17 | n/a | −$5.95 | |
| Q2 FY24 | −$5.05 | n/a | −$4.89 | |
| Q1 FY24 | $0.78 | n/a | $0.14 | |
| Q4 FY23 | −$0.51 | n/a | −$0.64 | |
| Q3 FY23 | −$0.11 | n/a | −$1.20 |
Against its peers
Companies in Financial - Credit Services nearest Core Scientific's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CORZCore Scientific | −$4.23 | |
| PAYPaymentus | $0.66 | +53% a year |
| NNINelnet | $8.36 | −7% a year |
| ENVAEnova International | $14.50 | +33% a year |
| SEZLSezzle | $4.56 | +56% a year |
| DAVEDave | $15.42 | +308% a year |
| BFHBread Financial | $12.83 | +117% a year |
| SLMSLM | $2.76 | −3% a year |
| TNETTrinet | $3.73 | +28% a year |
| FIGRFigure Technology Solutions | $0.96 | +500% a year |
| RELYRemitly Global | $1.39 | +2217% a year |
| Peer median | $4.14 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Core Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.